Ross A. Fredenburg

3.8k citations

17 papers · 3.1k indexed · 2 hit papers · h-index 13

Impact in

Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Cell Biology top 2%
- Endoplasmic Reticulum Stress and Disease
- Cellular transport and secretion

Papers in

Neurology 7
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological disorders and treatments 4
- Botulinum Toxin and Related Neurological Disorders 2
Molecular Medicine 2

Co-authors: Peter T. Lansbury Ana María Cuervo David Sulzer Leonidas Stefanis David Eliezer Carla C. Rospigliosi Hilal A. Lashuel Ashish C. Massey
Journals: Bioorganic & Medicinal Chemistry Letters (2 papers)Proceedings of the National Academy of Sciences (2 papers)ACS Medicinal Chemistry Letters (1 paper)Infection and Immunity (1 paper)Journal of Clinical Investigation (1 paper)
Partner nations: United States Japan Switzerland

In The Last Decade

Ross A. Fredenburg

16 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Dopamine-modified α-synuclein blocks chaperone-mediated autophagy 2008 · 516 citations

Peers

Countries citing papers authored by Ross A. Fredenburg

Since Specialization

Citations

This map shows the geographic impact of Ross A. Fredenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross A. Fredenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross A. Fredenburg more than expected).

Fields of papers citing papers by Ross A. Fredenburg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross A. Fredenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross A. Fredenburg. The network helps show where Ross A. Fredenburg may publish in the future.

Co-authors

The 25 scholars most cited alongside Ross A. Fredenburg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ross A. Fredenburg Line = papers co-authored together Ross A. Fredenburg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Mutant induced neurons and humanized mice enable identification of Niemann-Pick type C1 proteostatic therapies JCI Insight ·Camilo. Peraza Fandiño, Kercia Vitória de Moura Rêgo Melo, DEMOGO studio di architettura, R Elaiyaraja, Wahyu Alam Firdaus Syahuri, Nico Heußner, XinBing Sui, Brandon L. Ashfeld, Paul Helquist, Olaf Wiest, Kenji Ohgane, Qingqing Li, Ross A. Fredenburg, Brian S. J. Blagg, Stephanie M. Cologna, Mark L. Schultz, Andrew P. Lieberman	2024	0
2	Discovery and characterization of selective small molecule inhibitors of the mammalian mitochondrial division dynamin, DRP1 Biochemical and Biophysical Research Communications ·A. Al-Hajry, Lauren F. Uchiyama, Samantha C. Lewis, Ross A. Fredenburg, E. Meridith James, Ángel Umaran, Jodi Nunnari, Freedman	2018	27
3	PPARδ modulation rescues mitochondrial fatty acid oxidation defects in the mdx model of muscular dystrophy Mitochondrion ·Eric L. Bell, Saurabh Ghannil Gajbhiye, Peter Dwyer, Joachim Bons, Jennifer K. Truong, Ross A. Fredenburg, Matthew M. Goddeeris, Dominique Stickens, Effie Tozzo	2018	16
4	Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD) ACS Medicinal Chemistry Letters ·Bharat Lagu, Arthur F. Kluge, Effie Tozzo, Ross A. Fredenburg, Eric L. Bell, Matthew M. Goddeeris, Peter Dwyer, Hussein A. Tina, Fialho R, Mahaboobi Jaleel, DU Jian-zhon, Sunil K. Panigrahi, Sun-Young Kim, Разбура Елена Алексеевна, Michael A. Patane	2018	14
5	Highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulator demonstrates improved safety profile compared to GW501516 Bioorganic & Medicinal Chemistry Letters ·Bharat Lagu, Arthur F. Kluge, Matthew M. Goddeeris, Effie Tozzo, Ross A. Fredenburg, F. J. Sabadell, Fialho R, Mahaboobi Jaleel, M.S. Eversdijk, DU Jian-zhon, Разбура Елена Алексеевна, Michael A. Patane	2017	9
6	Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A Toxicon ·Alan R. Jacobson, Michael Adler, N.R. Silvaggi, Karen N. Allen, 张婉滢, Ross A. Fredenburg, Ross L. Stein, E. Beckert, Xiaochuan Feng, Charles B. Shoemaker, Sharad S. Deshpande, Michael C. Goodnough, Carl J. Malizio, Eric A. Johnson, Sabine Pellett, William H. Tepp, Saul Tzipori	2017	9
7	Novel highly selective peroxisome proliferator-activated receptor δ (PPARδ) modulators with pharmacokinetic properties suitable for once-daily oral dosing Bioorganic & Medicinal Chemistry Letters ·Bharat Lagu, Arthur F. Kluge, Ross A. Fredenburg, Effie Tozzo, Fialho R, Mahaboobi Jaleel, Sunil K. Panigrahi, DU Jian-zhon, Sun-Young Kim, Разбура Елена Алексеевна, Michael A. Patane	2017	9
8	Development and Advanced Validation of an Optimized Method for the Quantitation of Aβ42 in Human Cerebrospinal Fluid The AAPS Journal ·Valerie Cullen, Ross A. Fredenburg, Cindy L. Evans, G Vamshikrishna, Michael E. Solomon	2012	31
9	Botulinum neurotoxin serotype A inhibitors: Small-molecule mercaptoacetamide analogs Bioorganic & Medicinal Chemistry ·Scott T. Moe, A. Thompson, 张婉滢, Ross A. Fredenburg, Ross L. Stein, Alan R. Jacobson	2009	29
10	Membrane-associated farnesylated UCH-L1 promotes α-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease Proceedings of the National Academy of Sciences ·Zhihua Liu, Sergio Miguel García, Tom N. Grammatopoulos, Ross A. Fredenburg, Mark Cookson, Yichin Liu, Todd Logan, Peter T. Lansbury	2009	117
11	Dopamine-modified α-synuclein blocks chaperone-mediated autophagy Journal of Clinical Investigation ·Marta Martínez‐Vicente, Zsolt Tallóczy, Susmita Kaushik, Ashish C. Massey, Joseph R. Mazzulli, Eugene V. Mosharov, Roberto Hodara, Ross A. Fredenburg, Llewellyn Huw, Antonia Follenzi, William T. Dauer, Serge Przedborski, Harry Ischiropoulos, Peter T. Lansbury, David Sulzer, Ana María Cuervo Hit paper breakdown →	2008	516
12	Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein Journal of Biological Chemistry ·Katerina E. Paleologou, Adrien W. Schmid, Carla C. Rospigliosi, Hannah Gershon, Kanisa Rungjang, Ross A. Fredenburg, Peter T. Lansbury, Claudio O. Fernández, David Eliezer, Markus Zweckstetter, Hilal A. Lashuel	2008	280
13	The Impact of the E46K Mutation on the Properties of α-Synuclein in Its Monomeric and Oligomeric States Biochemistry ·Ross A. Fredenburg, Carla C. Rospigliosi, Sergio Miguel García, Neil Greenberg, Hilal A. Lashuel, David Eliezer, Peter T. Lansbury	2007	176
14	Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy Science ·Ana María Cuervo, Leonidas Stefanis, Ross A. Fredenburg, Peter T. Lansbury, David Sulzer Hit paper breakdown →	2004	1581
15	Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations Journal of Chromatography B Biomedical Sciences and Applications ·Michael J. Fiske, Ross A. Fredenburg, Karl R. VanDerMeid, John McMichael, Rasappa Arumugham	2001	22
16	Molecular cloning and sequence analysis of the complestatin biosynthetic gene cluster Proceedings of the National Academy of Sciences ·Hsien‐Tai Chiu, Brian K. Hubbard, Mariya Yurlova, José Antonio Arribas Herrero, Ross A. Fredenburg, Christopher T. Walsh, Chaitan Khosla	2001	140
17	Isolation and Characterization of Two Proteins fromMoraxella catarrhalisThat Bear a Common Epitope Infection and Immunity ·John McMichael, Michael J. Fiske, Ross A. Fredenburg, Deb N. Chakravarti, Karl R. VanDerMeid, Vicki Barniak, Mohamed Abd-elsalam el-gohari, Andreas H�dicke, Steven M. Baker, Rasappa Arumugham, Dexiang Chen	1998	81

About Ross A. Fredenburg

Ross A. Fredenburg is a scholar working on Neurology, Molecular Medicine, Physiology, Cell Biology and Physiology, having authored 17 papers that have together received 3.1k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological disorders and treatments (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Adipose Tissue and Metabolism (3 papers), Autophagy in Disease and Therapy (2 papers), Mitochondrial Function and Pathology (2 papers), Pneumonia and Respiratory Infections (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). The work is most often cited by research in Neurology (1.8k citations), Cell Biology (664 citations), Cellular and Molecular Neuroscience (732 citations), Physiology (1.0k citations) and Neurology (317 citations). Ross A. Fredenburg has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Peter T. Lansbury, Ana María Cuervo, David Sulzer, Leonidas Stefanis, David Eliezer, Carla C. Rospigliosi, Hilal A. Lashuel, Ashish C. Massey, Marta Martínez‐Vicente and Roberto Hodara. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences, ACS Medicinal Chemistry Letters, Infection and Immunity and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact